We are live on ! Find out more
RVM

RiverVest Venture Management Portfolio holdings

AUM $6.84M
1-Year Est. Return 7.71%
This Fund
S&P 500
This Quarter Est. Return
+13.45%
1 Year Est. Return
-7.71%
3 Year Est. Return
-16.51%
5 Year Est. Return
10 Year Est. Return
AUM
$85.7M
AUM Growth
-$403K
Cap. Flow
-$5.93M
Cap. Flow %
-6.92%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
MIRM icon
Mirum Pharmaceuticals
MIRM
+$5.93M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLK
1
DELISTED
Allakos
ALLK
$41.2M 48.01%
4,887,932
MIRM icon
2
Mirum Pharmaceuticals
MIRM
$6.08B
$31.6M 36.87%
1,621,118
-300,000
-16% -$5.93M
OKUR
3
OnKure Therapeutics
OKUR
$155M
$5.61M 6.55%
240,922
XLO icon
4
Xilio Therapeutics
XLO
$59.3M
$3.88M 4.52%
102,960
SPRB
5
Spruce Biosciences
SPRB
$182M
$2.36M 2.75%
28,644
VAPO
6
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$1.11M 1.3%
51,570

Similar funds

RiverVest Venture Management's Q4 2022 Portfolio in Review

As of Q4 2022, RiverVest Venture Management held 6 positions worth $85.7M, down 0.47% from $86.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

RiverVest Venture Management withdrew a net $5.93M in Q4 2022, reducing 1 holding. Its largest reduction was Mirum Pharmaceuticals, cutting an estimated $5.93M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • RiverVest Venture Management's biggest Q4 2022 reduction was Mirum Pharmaceuticals, cutting an estimated $5.93M.
  • RiverVest Venture Management's ten largest holdings make up 100% of its $85.7M portfolio in Q4 2022.
  • RiverVest Venture Management opened 0 new positions and closed 0 in Q4 2022.
  • RiverVest Venture Management's portfolio value fell 0.47% quarter-over-quarter to $85.7M.

Based on RiverVest Venture Management's 13F filing for Q4 2022, filed 14 Feb 2023.